Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Osteoporosis: Part II. Prevention of Bone Loss and Fractures in Women and Risks of Menopausal Estrogen Therapy.

Literature DB >> 18749430

Osteoporosis: Part II. Prevention of Bone Loss and Fractures in Women and Risks of Menopausal Estrogen Therapy.

Abstract

These discussions are selected from the weekly staff conferences in the Department of Medicine, University of California, San Francisco. Taken from transcriptions, they are prepared by Drs Homer A. Boushey, Associate Professor of Medicine, and David G. Warnock, Associate Professor of Medicine, under the direction of Dr Lloyd H. Smith, Jr, Professor of Medicine and Chairman of the Department of Medicine. Requests for reprints should be sent to the Department of Medicine, University of California, San Francisco, School of Medicine, San Francisco, CA 94143.

Entities: Disease Species

Year: 1983 PMID： 18749430 PMCID： PMC1010931

Source DB: PubMed Journal: West J Med ISSN： 0093-0415

37 in total

1. Estrogens and endometrial cancer in a retirement community.

Authors: T M Mack; M C Pike; B E Henderson; R I Pfeffer; V R Gerkins; M Arthur; S E Brown
Journal: N Engl J Med Date: 1976-06-03 Impact factor: 91.245

2. Increased risk of endometrial carcinoma among users of conjugated estrogens.

Authors: H K Ziel; W D Finkle
Journal: N Engl J Med Date: 1975-12-04 Impact factor: 91.245

3. [Sex hormones and calcitonin secretion].

Authors: H P Klotz; M L Delorme; F Ochoa; C Aussenard
Journal: Sem Hop Date: 1975-04-26

4. Menopausal estrogens and breast cancer.

Authors: R Hoover; L A Gray; P Cole; B MacMahon
Journal: N Engl J Med Date: 1976-08-19 Impact factor: 91.245

5. Metabolic and hormonal effects of post-menopausal oestrogen replacement treatment. II. Plasma lipids.

Authors: L Wallentin; U Larsson-Cohn
Journal: Acta Endocrinol (Copenh) Date: 1977-11

6. A case-control study of menopausal estrogen therapy and breast cancer.

Authors: R K Ross; A Paganini-Hill; V R Gerkins; T M Mack; R Pfeffer; M Arthur; B E Henderson
Journal: JAMA Date: 1980-04-25 Impact factor: 56.272

7. Post-menopausal oestrogens protect against fractures of hip and distal radius. A case-control study.

Authors: T A Hutchinson; S M Polansky; A R Feinstein
Journal: Lancet Date: 1979-10-06 Impact factor: 79.321

8. Altered plasma lipid and lipoprotein levels associated with oral contraceptive and oestrogen use. Report from the Medications Working Group of the Lipid Research Clinics Program.

Authors: R B Wallace; J Hoover; E Barrett-Connor; B M Rifkind; D B Hunninghake; A Mackenthun; G Heiss
Journal: Lancet Date: 1979-07-21 Impact factor: 79.321

Osteoporosis: Part II. Prevention of Bone Loss and Fractures in Women and Risks of Menopausal Estrogen Therapy.

1. Estrogens and endometrial cancer in a retirement community.

2. Increased risk of endometrial carcinoma among users of conjugated estrogens.

3. [Sex hormones and calcitonin secretion].

4. Menopausal estrogens and breast cancer.

5. Metabolic and hormonal effects of post-menopausal oestrogen replacement treatment. II. Plasma lipids.

6. A case-control study of menopausal estrogen therapy and breast cancer.

7. Post-menopausal oestrogens protect against fractures of hip and distal radius. A case-control study.

8. Altered plasma lipid and lipoprotein levels associated with oral contraceptive and oestrogen use. Report from the Medications Working Group of the Lipid Research Clinics Program.

9. Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen.

10. Relative deficiency of plasma-calcitonin in normal women.

1. Preventive medicine and public health: preventing osteoporosis.

2. Should postmenopausal women be given estrogen?

3. Bone mineral changes in primary hyperparathyroidism.